$Cladribine-based debulking chemotherapy sequential with reduced intensity regimen and post-transplantation maintenance for refractory myeloid leukemia: a prospective phase II clinical trial$

Cladribine-based debulking chemotherapy sequential with reduced intensity regimen and post-transplantation maintenance for refractory myeloid leukemia: a prospective phase II clinical trial

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2022-06, Vol.57 (6), p.1004-1006
Hauptverfasser:	Wang, Ling, Gao, Wenhui, Wang, Lining, Wan, Min, Jiang, Jieling, Hu, Jiong
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/2779/109/1941 692/699/1541/1990/283/1897 Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cell Biology Chemotherapy Cladribine Cladribine - pharmacology Cladribine - therapeutic use Correspondence Cytarabine - therapeutic use Cytoreduction Surgical Procedures Hematology Hematopoietic Stem Cell Transplantation Humans Internal Medicine Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute - drug therapy Medicine Medicine & Public Health Myeloid leukemia Prospective Studies Public Health Remission Induction Stem Cells Transplantation Transplantation Conditioning
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!